Clinical Trial Update: Racotumomab in Patients With High-risk Neuroblastoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Racotumomab in high-risk neuroblastoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• Racotumomab (racotumomab)

Snippet

Sponsor: Laboratorio Elea Phoenix S.A. | Conditions: Neuroblastoma | Phase 2 | Status: COMPLETED